Local 12: Trial looks at treating pneumonia associated with COVID-19
Study examines anti-viral medication that could help reduce common complication of the coronavirus
A breakthrough trial is looking at a new anti-viral medication that could help reduce one of the most common complications of the COVID-19 coronavirus: pneumonia.
This new trial is one of a handful across the country looking at an antiviral therapy intended to stop the spread of this virus.
A team at the University of Cincinnati is conducting this research. Brett Kissela, MD, senior associate dean of clinical research at the UC College of Medicine and UC Health physician, is featured.
Read more about UC-led clinical trials.
Featured photo/Colleen Kelley/UC Creative + Brand
Related Stories
What Is Public Health Nursing? Career path and whether it’s right for you
April 6, 2026
When nurses consider graduate school, many immediately think of becoming a nurse practitioner. But there is another advanced path that is growing in demand, one focused not on treating individual patients, but on improving the health of entire communities: public health nursing.
A day of hoops and fun supports families impacted by homelessness
April 6, 2026
CPS All-Star Showcase returned to UC’s Fifth Third Arena, Saturday, April 4, highligting the partnership between Cincinnati Public Schools and the University of Cincinnati. Local media covered the daylong sports event which showcased some Cincinnati's finest high school athletes. Proceeds from the event benefited Project Connect.
What is the 'cicada' COVID variant?
April 6, 2026
A formerly rare strain of COVID, BA.3.2, now is showing up in Ohio and 24 other states. Experts say so far it hasn't caused illness any more severe than other strains, but it might be somewhat more resistant to vaccines, as 91.7 WVXU News recently reported. Scientists have nicknamed the variant "cicada" due to its former low profile and current resurgence.